Updates Immunovant: IMVT-1401’s Indication Expansion, $444M In Cash And New Management by Kourosh MaheriJanuary 14, 2021 Kourosh Maheri See author's posts Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Like this:Like Loading... Related
by 
